SSKN News and Press, Strata Skin Sciences Inc. From 03/30/22

HORSHAM, Pa., March 30, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of various autoimmune skin diseases, today announced that it has become...

HORSHAM, Pa., March 28, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced today that it will be participating in ...

The following slide deck was published by STRATA Skin Sciences, Inc. in conjunction with this event. For further details see: STRATA Skin Sciences (SSKN) Investor Presentations - Slideshow

Gainers: Clever Leaves (CLVR) +28%. Tilray Brands (TLRY) +13%. Cutera (CUTR) +11%. STRATA Skin Sciences (SSKN) +10%. Clarus Therapeutics (CRXT) +8%. Losers: MEI Pharma (MEIP) -58%. Icosavax (ICVX) -50%. Rezolute (RZLT) -9%. Alpha Tau Medical (...

Buying Penny Stocks Today? Here’s What You Need to Know If you’re looking to find the best penny stocks to buy today, there are numerous options to choose from. Because of this, it all comes down to understanding what is going on in the stock market and how to take advanta...

Clever Leaves Holdings (CLVR) +34% on Q4 results. Tilray Brands (TLRY) +19%, Canopy Growth lead rally in marijuana stocks as legalization hopes return. STRATA Skin Sciences (SSKN) +17%. Aurora Cannabis (ACB) +15% Tilray, Canopy Growth lead rally in marijuana...

STRATA Skin Sciences, Inc. (SSKN) Q4 2021 Earnings Conference Call March 21, 2022 4:30 P.M. ET Company Participants Leigh Salvo - Investor Relations Robert Moccia - Chief Executive Officer Christopher Lesovitz - Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Th...

STRATA Skin Sciences press release (NASDAQ:SSKN): Q4 GAAP EPS of -$0.02 beats by $0.01. Revenue of $9.1M (+35.4% Y/Y) beats by $0.13M. Despite Omicron headwinds and insurance resets for the new year in Q1 2022, STRATA projects 2022 full year revenue to be between $33.0 million and $35.0 milli...

HORSHAM, Pa., March 21, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced financial results for the fourth ...

DRIO, KERN, NKE, SSKN, TME, VLTA For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings after Monday's close